Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.
Journal: The Journal of urology
Published: June 30, 2026
Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: May 27, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry.
Journal: Minerva urology and nephrology
Published: April 23, 2026
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group.
Journal: Cancers
Published: May 26, 2025
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer, a study with 5-year follow-up: a plain language summary.
Journal: Future oncology (London, England)
Published: May 21, 2025
Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer.
Journal: Journal of racial and ethnic health disparities
Published: April 29, 2025
Gender Disparities in Citations and Altmetric Attention Score in Oncology.
Journal: JCO oncology practice
Published: April 10, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group).
Journal: Minerva urology and nephrology
Published: April 04, 2025
Last Updated: 09/26/2026